JSB Market Research: Global and USA Cancer Biomarker Market to 2018 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

JSB Market Research: Global and USA Cancer Biomarker Market to 2018

Description:

JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ – PowerPoint PPT presentation

Number of Views:41

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: JSB Market Research: Global and USA Cancer Biomarker Market to 2018


1
GLOBAL USA CANCER BIOMARKER MARKET to 2018
(Identification, Technologies, Market Analysis,
Competitor Profiles, Companion Diagnostic
Co-Development, Business Strategies, Industry
Trends, and Pipeline Analysis)
To buy this Report Visit http//www.jsbmarketresea
rch.com/healthcare-medical/r-GLOBAL-USA-CANCER-BIO
MARKER-MARKET-115008
p
2
Summary
  • This is a comprehensive account of the
    market size, segmentation, key players, SWOT
    analysis, influential technologies, and business
    and economic environments. The report is
    supported by 280 tables figures over 232 pages.
    The oncology biomarker (globaland USA) market is
    presented as follows
  • By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA
    GENETICS, NODALITY, deCode /Amgen, CELERA,
    MYRIAD, FOUNDATION MEDICINE, GENOMIC HEALTH)
  • By Geography (Global, US)
  • By Sub-market (Global Biomarker Market, Cancer
    Biomarker Market, Global Cancer Profiling
    Technology Market )

p
3
Report Description
  • Cancer biomarkers are molecular or genetic
    moieties (e.g., cells, proteins/peptides, genetic
    mutations, gene products, enzymes, or hormones)
    that not only are readily identifiable, but
    easily quantified in the lab setting. They
    function primarily to identify or correlate
    significantly with the severity or occurrence of
    a certain disease state. The rise in number of
    oncogenic biomarkers over the last number of
    years has massive potential in the healthcare
    industry and serves to propel both the
    personalized medicine and companion diagnostic
    markets. One of the most import aspects of
    biomarkers is their use to diagnose and assess
    the progress of disease states in patients. As
    quantitative markers, these agents also offer the
    ability to monitor response to certain drug
    treatments and so are important in the area of
    personalized medicine. Individualized, targeted
    or personalized medicine aims to increase the
    efficacy of therapeutics via genetic testing and
    companion diagnostics. Personalized therapeutics
    and associated companion diagnostics will be more
    specific and effective thereby giving
    pharma/biotech companies a significant advantage
    to recuperate RD costs. Personalized medicine
    will reduce the frequency of adverse drug
    reactions and therefore have a dramatic impact on
    health economics. Developmental and diagnostic
    companies will benefit from lower discovery and
    commercialization costs and more specific market
    subtypes.

p
4
SWOT, Economic Regulatory Environment specifics
include
  • Key strengths, weaknesses and threats influencing
    leading player position within the market
  • Technologies driving the market (e.g.,
    New-Generation Sequencing Technologies,
    Ultra-High Throughput Sequencing)
  • Top fastest growing market segments and emerging
    opportunities
  • Top pharmaceutical companies within the cancer
    biomarker market
  • Comprehensive product portfolios, RD activity
    and pipeline therapeutics
  • MA activity and future strategies of top
    companies
  • Approved biomarker companion diagnostic tests
  • High demand and Unmet Need Enhances the Global
    Biomarker Market
  • FDA Support Increases Biomarker Development
  • More Streamlined Clinical Trials
  • Significant Growth of High-Impact Oncogenic
    Biomarker Research
  • Advancements in Discovery Technologies
  • Challenges of the Oncogenic Biomarker Market
  • Variability of Biomarkers within Different Cancer
    Subtypes
  • Integration of Genomics and Biomarker Diagnostics
    into the Healthcare System
  • Ethical Considerations

p
5
Global and USA Cancer Biomarker Market
Global Burden of Cancer
Oncogenic Biomarkers An Overview
Current and Prospective Oncogenic Biomarkers
Biomarker Validation
p
6
Price Chart
  • GLOBAL USA CANCER BIOMARKER MARKET to 2018
    (Identification, Technologies, Market Analysis,
    Competitor Profiles, Companion Diagnostic
    Co-Development, Business Strategies, Industry
    Trends, and Pipeline Analysis)

License Type Price
PDF 3400
Enterprise Wide Licence 6800
To View OR Purchase Report
http//www.jsbmarketresearch.com/healthcare-medica
l/r-GLOBAL-USA-CANCER-BIOMARKER-MARKET-115008
p
7
Related Market Research Report
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-Ablation-Technologies-Market-by-Product-125383
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-Gastric-Motility-Disorder-Pipeline-Review-H2-2
    014-125477
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-Iron-Deficiency-Anemia-Pipeline-Review-H2-2014
    -125478
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-Hospital-Acquired-Methicillin-Resistant-Staphy
    lococcus-Aureus-MRSA-Infections-Pipeline-Review-H2
    -2014-125479
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-Chronic-Cough-Pipeline-Review-H2-2014-125480

p
8
About JSB Market Research
  • Jsbmarketresearch.com is an online repository of
    an extensive collection of market research
    reports available online. This online portal
    contains high-quality reports with
    well-researched and high-quality content on a
    wide range of industries. These market research
    reports help us give a detailed insight into new
    opportunities in the industry, prevailing market
    trends, competitor analysis and future prospects.
  • JSBs reports are developed by the domain experts
    and publishers under a closely observed
    surveillance of industry specialists. Therefore,
    the researched data is well researched, well-
    organized and matching up to the best standards
    in the industry. Also JSBs database consists of
    detailed insights of the leading players in the
    global market, products and trends

p
9
Contact Us
  • Support General Inquiries
  • Mail support_at_jsbmarketresearch.com
    91 - 998 729 5242
  • Billing Support
  • Mail billing_at_jsbmarketresearch.com
    91 22 412 366 50
  • Website http//www.jsbmarketresearch.com

p
About PowerShow.com